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1. Introduction 
In a previous publication [l] * we have reported 
the presence of 22(R)-,* 23-, 24 and 26_hydroxychol- 
ester01 in the monosulphate fraction from meconium. 
During the course of this study some trihydroxy 
(C2703)sterols were also found in the monosulphate 
and “disulphate” fractions. This communication de- 
scribes the identification of one of the quantitatively 
predominating trihydroxy sterols, 20,22dihydroxy- 
cholesterol. 
2. Materials and methods 
Meconium was collected as described previously 
[l] .200 g of meconium was homogenized twice in 
500 ml of chloroform/methanol, 1:1 (v/v), and then 
in 500 ml of ethanol. After filtration and removal of 
solvents in YUCUO the residue was partitioned between 
700 ml of petroleum ether and 700 ml of aqueous 
* In our previous publication (FEBS Letters 3 (1969) 129) we 
reported the isolation of 22(@(22(S))-hydroxycholesterol. 
However, since then it has been brought to our attention that 
the confiration of naturally occurring 22-hydroxychol- 
ester01 has been revised and has been reported to be 220 
(22R) (by H.Mori, K.Shibata, K.Tsuneda, M.Sawari, and 
K.Tsuda in Chem. Pharm. BulL 16 (1968) 1407 and by E.P. 
Burrows, G.M.Hornby and E.Caspi in J.Org. Chem. 34 
(1969) 103). This is opposite to the previously accepted 
configuration and since our assignment of configuration of 
22-hydroxycholesteryl suiphate was based on comparisor 
with the natural product it has a 22p(22R) configuration 
instead of the 22cu(22S) reported in our paper. 
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ethanol (3:7, v/v). The ethanol phase was passed 
through a 25 g column of Amberlyst-15 (Rohm and 
Haas, Co., Philadelphia, Pa., USA) in the sodium form. 
The column was rinsed with 700 ml of ethanol. The 
residue obtained after evaporation of the solvent was 
chromatographed ona 400 g column of Sephadex 
LH-20 using chloroform/methanol, 1:1, containing 
0.01 moles/ 1 of sodium chloride, as the mobile phase 
[2] . The chromatography was evaluated by adding a 
tracer amount of the sodium salt of 3f3-hydroxyan- 
drost-5-en-l7-one-7c#H] sulphate to the sample 
applied to the column. The monosulphate fraction was 
collected between 2000 and 5000 ml of solvent and 
when it had been eluted the column was rinsed with 
5000 ml of methanol. The last fraction contained 
conjugates more polar than glucuronosides and sulphates 
and was called the “disulphate” fraction. The mono- 
sulphate and “disulphate” fractions were then eva- 
porated and the residues were solvolyzed over night 
in ethyl acetate acidified with 2 M H2SO4 [3]. The 
extracts were purified by chromatography on a 5 g 
Sephadex LH-20 column in chloroform [4]. Fractions 
of 3 ml were collected, evaporated under nitrogen and 
weighed. From each fraction 0.1 mg was taken and 
reacted with 0.3 ml hexamethyldisilazane, 0.05 ml 
trimethylchlorosilane and 0.5 ml pyridine. The re- 
agents were evaported under nitrogen. The residue was 
dissolved in hexane and injected into an LKB Gas 
Chromatograph-Mass Spectrometer quipped either 
with a 1% SE-30 or a 3% QF-1 column. The condi- 
tions were: flash heater temperature: 260°C; column 
temperature: 238’C; separator temperature: 260°C; 
ion source temperature: 29O’C; acceleration voltage: 
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3.5 kV; energy of the bombarding electrons: 22.5 eV. 
The steroids were analyzed as their trimethylsilyl 
(silyl) ether derivatives. Deuterium labelled silyl ethers 
were prepared with perdeuterotrimethylsilyl ch oride 
[5] (Merck Sharp and Dohme of Canada, Ltd., Mon- 
treal, Canada) in pyridine. Acetonides (Oisopropyli- 
dene derivatives) were prepared in 1 ml of acetone 
with 50 mg of anhydrous cupric sulphate. This mix- 
ture was allowed to stand for 1 hr at 60” with oc- 
casional stirring [6] . The mixture was then centri- 
fuged and the supematant was taken for analysis. 
3. Results 
The gas chromatographic analyses of solvolyzed 
mono- and “disulphate” sterol fractions eluted with 
chloroform from the Sephadex LH-20 column be- 
tween 1 .O and 1.2 total bed volumes [4] are shown 
in fig. 1. The composition of the dihydroxy sterols of 
the monosulphate fraction is that described previously 
[ 1,7] . One of these sterols, i.e. 22(R)-hydroxychol- 
esterol, is also found among the sterols from the 
“disulphate” fraction (peak A, lower panel). The 
major compound in this chromatogram (peak I) was 
also present among the monosulphate sterols and had 
a tR-value (Table) identical with that of 20(S), 22&d& 
hydroxycholesterol (kindly given to us by Dr. E. 
Forchielli) silylated with the standard procedure. 
Under more vigorous conditions both compounds 
gave rise to a tri(trimethylsiloxy) derivative. Mass 
spectrometry of the 3&22[-bis(trimethylsiloxy)-20(S)- 
hydroxy derivative (fig. 2) revealed an ion at m/e 173 
probably identical with the ion of mass 173 forming 
the base peak in the mass pectrum of 22-hydroxychol- 
ester01 silyl ether [7] (tentative structure: (CH3)$i& 
= CH-CH2--CH,-CH(CH&). However, prominent 
peaks are also found at m/e 389 (M-173) and 299 
(M-(90+1 73)) and thus the side chain fragment of mass 
173 can also be lost in a non-charged state (structure: 
(CH~)+O-CH-CH2-CH2-CH(CH&). These inter- 
pretations are supported by the mass pectrum of the 
deuterated silyl ether of 20,22-dihydroxycholesterol 
(fig. 2). This derivative gives prominent peaks at m/e 
182 (173+9), 299 and 398 (389t9). At least part of 
the ion at m/e 217 in the mass pectrum of the silyl 
ether probably represents he entire side chain; the 
deuterated silyl ether gives a much smaller peak at 
m/e 217 but a new peak at m/e 226 (217+9). 
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Fig. 1. Total ion current recording obtained in the gas chro- 
matography-mass pectrometry analysis (1% SE-30 column) 
of silyl ethers of solvolyzable steroids in meconium. The upper 
panel represents one fraction from a Sephadex LH-20 chro- 
matography of the solvolyzed monosulphates; the lower 
panel represents the analogous fraction,from an identical 
chromatography of the solvolyzed “disulphates”. A = 22(R)- 
hydroxycholesterol; B = 23-hydroxycholesterol; C = 24- 
hydroxycholesterol; D = 26.hydroxycholesterol; I = 20,22- 
hydroxycholesterol. The arrows indicate a twofold increase 
in sensitivities. The compounds eluted before 10 min are 
Cre and Car steroids. 
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Table 1 
Retention times relative to cholestane (tR) of the silyl (TMS) 
ethers and acetonides of isolated and authentic 20,2-%dihy- 
droxycholesterol 
Compound SE30 QF-1 
TMS Acetonide 
Authentic 20,22- 
dihydroxycholesterol 
4.21 3.25 4.53 
Isolated compound 4.21 3.21 4.55 
The acetonides of the authentic and the isolated 
20,22dihydroxycholesterol gave identical mass pec- 
tra (fig. 2). The molecular ion Q&530) was not seen. 
The ion of mass 185 represents he side chain and the 
other prominent peaks below m/e 185 are formed by 
cleavages in the side chain. The peak at m/e 59 is ubi- 
quitous in all acetonide spectra nd has been shown 
to correspond to protonated acetone [8]. 
4. Discussion 
Although gas chromatography and mass pectro- 
metry provided data for the establishment of a 20,22- 
dihydroxycholesterol structure for the major C27 
sterol in the “disulphate” fraction from human meco 
nium these methods did not permit conclusions re- 
garding the configuration of the side chain hydroxyl 
groups. The configuration of naturally occurring 20- 
hydroxycholesterol is 2OS(2ocU) [9] and that of 22- 
hydroxycholesterol is 22R(22/3) [lo]. Hence it seems 
logical to suggest that our compound is 20(S), 22(R)- 
dihydroxycholesterol. From the chromatographic 
data the occurrence in meconium of a trisulphate deri- 
vative of 20,22-dihydroxycholesterol cannot be ruled 
out. However, no steroid or sterol sulphate ster has 
so far been found in animal tissues having a tertiary 
alcohol group esterified with sulphuric acid. Further- 
more, since 22(R)-hydroxycholesterol occurs as a di- 
sulphate in meconium it seems reasonable to suggest 
that the compound present in human meconium is 
3P,22(R)-disulphoxycholest-5en-2O(S)-ol. It should 
be noted that phosphates [ 1 l] and glucuronosides 
[ 121 are not hydrolyzed in acidified ethyl acetate. 
20@),22&dihydroxycholesterol as well as 22(R)-hy- 
102 
droxy- and 20(S)-hydroxycholesterol have been sug- 
gested as intermediates in the conversion of cholesterol 
to pregnenolone (3fihydroxypregn5-en-20-one) but 
20@),22dihydroxycholesterol has not previously been 
found in animal tissues. However, the biological role 
of side chain hydroxylated cholesterol compounds i  
somewhat uncertain (for a detailed iscussion see 
ref. [9,13,14]). It is noteworthy that 20,22dihydroxy- 
cholesterol and 22(R)-hydroxycholesterol have only 
been isolated from sulphate ster fractions suggesting 
that they may be involved in a direct conversion of 
cholsteryl sulphate to pregnenolone sulphate. Our 
investigation also raises the question of a possible 
metabolic role of steryl disulphates. 
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